Technology
The company has developed a stable liquid form of acetylsalicylic acid, enabling new types of treatments that act locally instead of systemically.
About Auxesis Pharma
Auxesis Pharma – facts, development and future
Auxesis Pharma is a Swedish pharmaceutical company developing topical treatments focused on local pain control directly in the skin.
Development phase
After many years of research, the company is now entering the clinical phase with planned studies during 2026.
Future focus
The focus is on clinical studies, regulatory approvals, and commercialization of products such as ASA.P® and CoxyPet®.
Transparency
Auxesis Pharma actively communicates its development, milestones, and scientific progress through its website, LinkedIn, and investor communication.
Transparency and progress
A clear path from research to clinical development
Auxesis Pharma continues to build value through documented technology, regulatory steps, clinical preparation, and ongoing communication with the market.